Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Huadong Medicine Co., Ltd
  6. Summary
    000963   CNE0000011S1

HUADONG MEDICINE CO., LTD

(000963)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/13/2021 10/14/2021 10/15/2021 10/18/2021 10/19/2021 Date
34.26 33.53 33.45 33.06 33.12 Last
46583940 31860100 25775960 20432940 20917930 Volume
-1.38% -2.13% -0.24% -1.17% +0.18% Change
Estimated financial data (e)
Sales 2021 36 279 M 5 684 M 5 684 M
Net income 2021 2 830 M 443 M 443 M
Net cash position 2021 2 062 M 323 M 323 M
P/E ratio 2021 20,5x
Yield 2021 1,09%
Sales 2022 40 085 M 6 281 M 6 281 M
Net income 2022 3 344 M 524 M 524 M
Net cash position 2022 3 377 M 529 M 529 M
P/E ratio 2022 17,3x
Yield 2022 1,32%
Capitalization 57 954 M 9 080 M 9 081 M
EV / Sales 2021 1,54x
EV / Sales 2022 1,36x
Nbr of Employees 11 359
Free-Float 41,5%
More Financials
Company
HUADONG MEDICINE CO., LTD is a China-based comprehensive pharmaceutical company. The Company is mainly engaged in the research and development of pharmaceuticals, the production and sales of chemical drugs, bulk drugs and preparations of traditional Chinese medicine, the distribution and retails of pharmaceuticals, medicine modern logistics, health industry, and the manufacturing and sales of medical beauty products. 
Sector
Drug Retailers
Calendar
10/27Earnings Release
More about the company
Ratings of Huadong Medicine Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about HUADONG MEDICINE CO., LTD
09/17Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commerci..
CI
09/08HUADONG MEDICINE : and Insilico Medicine enter co-development partnership to advance oncol..
AQ
09/08Huadong Medicine and Insilico Medicine Enter Co-Development Partnership to Advance Onco..
CI
08/09Huadong Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 202..
CI
06/06HUADONG MEDICINE CO., LTD : Annual Report
CO
06/02Huadong Medicine Co., Ltd Announces 2020 Final Profit Distribution Plan to Be Implement..
CI
05/24Huadong Medicine Co., Ltd Announces Dividend for 2020
CI
04/28HUADONG MEDICINE CO., LTD : 1st quarter report
CO
04/27Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31..
CI
04/21Huadong Medicine Co., Ltd Proposes Final Dividend for the Year 2020
CI
04/20Huadong Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31,..
CI
02/03R2 Dermatology Incorporated announced that it has received $30 million in funding from ..
CI
2020Huadong Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September ..
CI
2020HUADONG MEDICINE CO., LTD : 3rd quarter report
CO
2020Huadong Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 202..
CI
More news
News in other languages on HUADONG MEDICINE CO., LTD

- No features available -

More news
Chart HUADONG MEDICINE CO., LTD
Duration : Period :
Huadong Medicine Co., Ltd Technical Analysis Chart | 000963 | CNE0000011S1 | MarketScreener
Technical analysis trends HUADONG MEDICINE CO., LTD
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 33,12 CNY
Average target price 45,09 CNY
Spread / Average Target 36,1%
EPS Revisions
Managers and Directors
Liang Lü General Manager & Director
Hong Lan Ma Chief Financial Officer
Bang Liang Li Chairman
Xin Hua Bai Chairman-Supervisory Board
Lan Yang Independent Director
Sector and Competitors